Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 17320513646 |
| E-mail: | mike@molcoo.com |
| QQ: | 3001071511 |
| Skype: | Chat Now! |
| Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
|
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
|
| Product Name | MF | CAS | Details |
|---|
| [Phe13,Tyr19]-MCH (human, mouse, rat) | C109H160N30O26S4 | 160201-86-5 | Details |
| Laminin Nonapeptide, Amide | C40H63N13O13S | 110590-61-9 | Details |
| LHRH-Ⅲ, lamprey | C59H74N18O14 | 147859-97-0 | Details |
| Calcineurin Autoinhibitory Fragment | C124H205N39O39S2 | 148067-21-4 | Details |
| Mastoparan 7 | C67H124N18O15 | 145854-59-7 | Details |
| MBP MAPK Substrate | C39H70N18O11 | 138028-00-9 | Details |
| Calpain Inhibitor Peptide | C140H227N35O44S | 128578-18-7 | Details |
| [Tyr9]- β-MSH (porcine); (Tyr49)-β-Lipotropin (41-58) (porcine) | C101H140N24O30S | 198281-81-1 | Details |
| Laminin (929-933) | C26H42N8O8 | 110590-64-2 | Details |
| δ1-MSH, amide | C72H97N21O14S | 72629-65-3 | Details |
| Atrial Natriuretic Peptide (126-149) (rat) | C104H168N38O33S2 | 91421-87-3 | Details |
| Ac-[Lys0,Nle3]-g2-MSH amide | C83H116N24O17 | 237761-41-0 | Details |
| β- MSH, porcine | C98H138N26O29S | 19941-13-0 | Details |
| Tyr-Leptin (26-39) (human) | C80H137N19O25 | 309247-25-4 | Details |
| Proinsulin C - Peptide (31 - 63), porcine | C142H239N47O46 | 28152-90-1 | Details |
| α-Melanocyte Stimulating Hormone, acetylated-[D-Val13] (11-13) (MSHa) | C18H33N5O4 | 137359-89-8 | Details |
| β-MSH, human | C118H174N34O35S | 17908-57-5 | Details |
| [Ac-Cys4,DPhe7,Cys10] a-MSH (4-13), amide | C61H86N18O13S2 | 91050-39-4 | Details |
| [D-Pro194]-IL-1 b (193-195) (human) | C15H28N4O5 | 117027-34-6 | Details |
| Leptin (93-105) (human) | C64H110N20O23 | 200436-43-7 | Details |
| MAGE-3 Antigen (167-176), human | C53H80N12O16S | 178243-46-4 | Details |
| Polistes Mastoparan | C77H127N21O18 | 74129-19-4 | Details |
| cAMP Dependent PK Inhibitor (5-22), amide | C84H137N29O26 | 100853-58-5 | Details |
| HIV-1 tat Protein (49-57) | C53H106N30O11 | 123251-89-8 | Details |
| Endotoxin Inhibitor | C55H97N15O12S2 | 147396-10-9 | Details |
| Interleukin-1β Convertase Substrate | C68H105N21O23 | 143305-11-7 | Details |
| α-ANF(1-28), human | C127H205N45O39S3 | 91917-63-4 | Details |
| MAGE-3 Antigen (271-279), human | C53H79N13O10 | 160295-81-8 | Details |
| IL-8ra (9-29) | C112H150N24O38S2 | 188689-66-9 | Details |
| HIV-gp41-Fragment | C21H38N6O7 | 129426-47-7 | Details |
| Triptorelin, [DTrp6]-LH-RH, Amide | C64H82N18O13 | 57773-63-4 | Details |
| Influenza NP (147 - 155) | C48H82N16O14 | 132326-72-8 | Details |
| Leptin (22-56), human; | C171H298N50O56 | 183598-56-3 | Details |
| MSH Release Inhibiting Factor, amide | C13H24N4O3 | 2002-44-0 | Details |
| HIV-gp120- Fragment (308-331) | C114H199N41O31 | 115416-08-5 | Details |
| Laminin (925-933) | C40H62N12O14S | 110590-60-8 | Details |
| γ2 - MSH (41 - 58), amide | C74H100N22O15S | 799841-81-9 | Details |
| Melanocyte Protein PMEL 17 (44-59) (human, bovine, mouse) | C95H137N27O28 | 195523-86-5 | Details |
| MBP (1 - 11), mouse | C53H95N21O18 | 125366-42-9 | Details |
| HIV -gp120- Fragment (254-274) | C95H162N28O30S | 113944-46-0 | Details |
| Atrial Natriuretic Peptide (126-150) (rat) | C113H177N39O35S2 | 90052-57-6 | Details |
| Atrial Natriuretic Peptide (1-28), rat | C128H205N45O39S2 | 88898-17-3 | Details |
| [Ser140]-Myelin Proteolipid Protein (139-151) (depalmitoylated), human, bovine, dog, mouse, rat | C72H104N20O17 | 122018-58-0 | Details |
| [D-Phe2,6,Pro3]-LHRH | C59H80N14O13 | 67019-15-2 | Details |
| LHRH, salmon | C60H73N15O13 | 86073-88-3 | Details |
| β-Interleukin I (163-171), human | C39H64N12O19 | 106021-96-9 | Details |
| [Des-Acetyl]-a-MSH | C75H107N21O18S | 53697-27-1 | Details |
| Allatotropin, Mas – AT | C65H103N19O17S2 | 120928-88-3 | Details |
| Delta-MSH | C37H57N11O11S | 100930-04-9 | Details |
| [Leu144, Arg147] - PLP (139 - 151), [L144, R147 - PLP(139 - 151)] | C67H110N20O17 | 188859-65-6 | Details |
| [Pyr4] - MBP (4 - 14) | C60H100N20O17 | 136132-68-8 | Details |
| Mastoparan X | C73H126N20O15S | 72093-22-2 | Details |
| Leptin (116-130), mouse | C64H109N19O24S | 258276-95-8 | Details |
| MART-1 (26-35) (human) | C42H74N10O14 | 156251-01-3 | Details |
| [Des-Asp187,Met186]-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | C43H69N9O11S | 255710-51-1 | Details |
| Laminin Penta Peptide, amide | C26H43N9O7 | 110590-65-3 | Details |
| HIV -gp120- Antigenic Peptide | C117H211N41O31S | 198636-94-1 | Details |
| Mastoparan | C70H131N19O15 | 72093-21-1 | Details |
| HIV -gp120- Fragment (421-438) | C99H148N24O25S2 | 129318-38-3 | Details |
| Influenza HA (307 - 319) | C69H118N18O19 | 528526-85-4 | Details |
| C-Type Natriuretic Peptide (1-22), human | C93H157N27O28S3 | 127869-51-6 | Details |
| HIV Integrase Protein Inhibitor(1) | C46H55N11O7S | 172546-75-7 | Details |
| MCH-Gene-Overprinted-Polypeptide-14 (rat) | C80H132N22O18S3 | 182917-44-8 | Details |
| IGF-I (24-41) | C88H133N27O28 | 135861-49-3 | Details |
| MMP-3 Inhibitor I | C27H46N10O9S | 158841-76-0 | Details |
| MART-1 (27-35) (human) | C37H67N9O11 | 156251-11-5 | Details |
| Leucokinin IV | C41H52N12O12 | 104958-72-7 | Details |
| Protein Kinase C (19-36); Protein Kinase C Selective Inhibitor Protein | C93H159N35O24 | 113731-96-7 | Details |
| Formyl-LHRH (2-10) | C51H70N16O12 | 211376-91-9 | Details |
| [D-Leu2]-Melanocyte-Stimulating Hormone-Release Inhibiting Factor | C13H24N4O3 | 39705-60-7 | Details |
| Macrophage Inhibitory Peptide | C15H28N4O5 | 41961-56-2 | Details |
| [Des-Asp187]-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | C42H67N9O12 | 319927-23-6 | Details |
| Influenza A NP(366 - 374) Strain A/PR/8/35 | C38H63N11O18S2 | 132326-73-9 | Details |
| Leucokinin II | C39H50N10O12 | 104821-31-0 | Details |
| MBP (87-99), human; Myelin Basic Protein (87-99), guinea pig, human | C74H114N20O17 | 118506-26-6 | Details |
| γ-MSH (3-8) | C39H52N12O7S | 98640-70-1 | Details |
| Influenza HA (110 - 119) | C63H90N14O16 | 132031-50-6 | Details |
| [D-Arg6,Asn10]-MCH (6-16) amide (human, mouse, rat) | C60H100N22O14S3 | 440635-61-0 | Details |
| Ecdysis-Triggering Hormone (Manduca sexta) ; Mas-ETH | C127H206N36O38S3 | 172519-53-8 | Details |
| β-MSH, monkey | C98H138N28O29S | 17750-75-3 | Details |
| [Des-Gly10,Dleu6, ProNHEt9] LH-RH, AcetateLeuprolide, Acetate | C61H88N16O14 | 74381-53-6 | Details |
| Hypercalcemia Malignancy Factor (1-40) | C180H287N57O48 | 112540-82-6 | Details |
| IGF-I (30-41) | C51H83N19O19 | 82177-09-1 | Details |
| [Ala9] Autocamtide 2; Autocamtide-2-Related Inhibitory Peptide | C64H116N22O19 | 167114-91-2 | Details |
| Hypercalcemia Malignancy Factor (1-34), amide, human | C180H288N58O47 | 112955-31-4 | Details |
| Mage-1 Antigen (161-169), human | C41H57N11O17 | 144449-86-5 | Details |
| Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | C46H72N10O15 | 162558-10-3 | Details |
| Influenza HA (518 - 526) | C42H69N9O15 | 186302-15-8 | Details |
| IL-8 Inhibitor | C45H66N18O7S | 138559-60-1 | Details |
| Hypercalcemia Malignancy Factor (7-34), amide, human | C153H247N49O37 | 115695-30-2 | Details |
| IGF-II (33-40) | C38H74N20O12 | 103244-41-3 | Details |
| [Des-Gly77,His78] Myelin Basic Protein (68-84), bovine | C71H113N23O28 | 98474-59-0 | Details |
| Leucokinin III | C40H52N12O13 | 104958-71-6 | Details |
| β-Lipotropin (61-69) | C47H70N12O15S | 72826-15-4 | Details |
| C-Type Natriuretic Peptide (1-53) (human) | 141294-77-1 | Details |
| [Gln8] LH-RH, chicken | C54H71N15O14 | 47922-48-5 | Details |
| LHRH (4-10) | C33H53N11O9 | 51776-33-1 | Details |
| γ3-MSH | C126H188N44O37S | 72629-64-2 | Details |
| MBP (1-11), human | C52H88N22O17 | 106128-98-7 | Details |
| [Tyr0]-C-Type Natriuretic Peptide (32-53) (human, porcine, rat) | C102H166N28O30S3 | 142878-79-3 | Details |
| Product Total： Product Page： | ||||
| 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 | ||||